These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9397991

  • 1. Hepatic expression of c-Myb in chronic human liver disease.
    Kitada T, Seki S, Nakatani K, Kawada N, Kuroki T, Monna T.
    Hepatology; 1997 Dec; 26(6):1506-12. PubMed ID: 9397991
    [Abstract] [Full Text] [Related]

  • 2. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E.
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [Abstract] [Full Text] [Related]

  • 3. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G, Franchitto A, Morini S, Corradini SG, Merli M, Gaudio E.
    Ital J Anat Embryol; 2004 May; 109(4):225-38. PubMed ID: 15717457
    [Abstract] [Full Text] [Related]

  • 4. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.
    Guido M, Rugge M, Leandro G, Fiel IM, Thung SN.
    Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139
    [Abstract] [Full Text] [Related]

  • 5. GFAP expression in the liver as an early marker of stellate cells activation.
    Morini S, Carotti S, Carpino G, Franchitto A, Corradini SG, Merli M, Gaudio E.
    Ital J Anat Embryol; 2005 Aug; 110(4):193-207. PubMed ID: 16536051
    [Abstract] [Full Text] [Related]

  • 6. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
    Tomanovic NR, Boricic IV, Brasanac DC, Stojsic ZM, Delic DS, Brmbolic BJ.
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
    [Abstract] [Full Text] [Related]

  • 7. Hepatic stellate cells in human schistosomiasis mansoni: a comparative immunohistochemical study with liver cirrhosis.
    Chang D, Ramalho LN, Ramalho FS, Martinelli AL, Zucoloto S.
    Acta Trop; 2006 Mar; 97(3):318-23. PubMed ID: 16473318
    [Abstract] [Full Text] [Related]

  • 8. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
    Tsamandas AC, Thomopoulos K, Zolota V, Kourelis T, Karatzas T, Ravazoula P, Tepetes K, Petsas T, Karavias D, Karatza C, Bonikos DS, Gogos C.
    Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
    [Abstract] [Full Text] [Related]

  • 9. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
    Khan MA, Poulos JE, Brunt EM, Li L, Solomon H, Britton RS, Bacon BR, Di Bisceglie AM.
    Hepatogastroenterology; 2001 Dec; 48(37):212-5. PubMed ID: 11268968
    [Abstract] [Full Text] [Related]

  • 10. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.
    Schmitt-Gräff A, Krüger S, Bochard F, Gabbiani G, Denk H.
    Am J Pathol; 1991 May; 138(5):1233-42. PubMed ID: 2024709
    [Abstract] [Full Text] [Related]

  • 11. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
    Leicester KL, Olynyk JK, Brunt EM, Britton RS, Bacon BR.
    Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000
    [Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
    Sakaida I, Nagatomi A, Hironaka K, Uchida K, Okita K.
    Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
    Akyol G, Erdem O, Yilmaz G.
    Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
    [Abstract] [Full Text] [Related]

  • 15. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
    Hellerbrand C, Bataille F, Schlegel J, Hartmann A, Mühlbauer M, Schölmerich J, Büttner R, Hofstädter F, Bosserhoff AK.
    Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Disease- and cell-specific expression of GP73 in human liver disease.
    Iftikhar R, Kladney RD, Havlioglu N, Schmitt-Gräff A, Gusmirovic I, Solomon H, Luxon BA, Bacon BR, Fimmel CJ.
    Am J Gastroenterol; 2004 Jun; 99(6):1087-95. PubMed ID: 15180730
    [Abstract] [Full Text] [Related]

  • 18. Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C.
    El-Karef A, Kaito M, Tanaka H, Ikeda K, Nishioka T, Fujita N, Inada H, Adachi Y, Kawada N, Nakajima Y, Imanaka-Yoshida K, Yoshida T.
    J Hepatol; 2007 Apr; 46(4):664-73. PubMed ID: 17188391
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A, Nosseir M, Zoheiry M, El-Ahwany E, Ghali A, El-Bassiouni N.
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [Abstract] [Full Text] [Related]

  • 20. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers.
    Takahara T, Furui K, Yata Y, Jin B, Zhang LP, Nambu S, Sato H, Seiki M, Watanabe A.
    Hepatology; 1997 Dec; 26(6):1521-9. PubMed ID: 9397993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.